908 Devices Inc. (MASS) — SEC Filings
908 Devices Inc. (MASS) — 41 SEC filings. Latest: 10-Q (May 6, 2026). Includes 14 8-K, 7 10-Q, 7 SC 13G/A.
View 908 Devices Inc. on SEC EDGAR
Overview
908 Devices Inc. (MASS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEFA14A filed on Apr 29, 2026: 908 Devices Inc. filed a Definitive Additional Materials (DEFA14A) on April 29, 2026. This filing contains additional proxy soliciting materials related to the company's business. The filing is associated with SEC Accession Number 0001104659-26-050801.
Sentiment Summary
Across 41 filings, the sentiment breakdown is: 3 bullish, 1 bearish, 36 neutral, 1 mixed. The dominant filing sentiment for 908 Devices Inc. is neutral.
Filing Type Overview
908 Devices Inc. (MASS) has filed 7 10-Q, 14 8-K, 1 ARS, 1 DEFA14A, 2 DEF 14A, 2 8-K/A, 2 10-K, 7 SC 13G/A, 5 SC 13G with the SEC between Jan 2024 to May 2026.
Filings by Year
Recent SEC Filings (41)
Risk Profile
Risk Assessment: Of MASS's 26 recent filings, 1 were flagged as high-risk, 10 as medium-risk, and 15 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $38,817,000 |
| Net Income | $15,315,000 |
| EPS | N/A |
| Debt-to-Equity | 0.40 |
| Cash Position | $62,802,000 |
| Operating Margin | N/A |
| Total Assets | $190,873,000 |
| Total Debt | $22,495,000 |
Key Executives
- Burlington, MA
- Fenel M. Eloi
- Jeffery P. George
- CLINTON BYBEE
- KEITH CRANDELL
- ROBERT NELSEN
Industry Context
908 Devices operates in the analytical instruments market, specifically focusing on mass spectrometry and spectroscopy technologies for chemical analysis. This sector is characterized by rapid technological advancements, demand for portability and ease of use, and stringent performance requirements. Key trends include the increasing adoption of portable devices for field applications and the integration of AI for data analysis. The competitive landscape includes established players and innovative startups, driving a need for continuous R&D and strategic acquisitions to expand product portfolios and market reach.
Top Tags
amendment (5) · sec-filing (4) · corporate-governance (4) · financials (4) · financial-statements (4) · financial-reporting (3) · 10-Q (3) · exhibits (3) · institutional-ownership (3) · disclosure (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| DEFA14A Document Size | 15033 | Indicates the size of the primary filing document in KB. |
| Complete Submission Text File Size | 442347 | Represents the total size of the submission in KB. |
| Net income | $15.315M | for the nine months ended September 30, 2025, a significant improvement from a $52.760M net loss in 2024 |
| Gain on sale of Desktop Portfolio | $56.128M | primary driver of net income for the nine months ended September 30, 2025 |
| Total revenue | $38.817M | for the nine months ended September 30, 2025, up 16.2% from $33.403M in 2024 |
| Net loss | $14.982M | for the three months ended September 30, 2025, an improvement from a $29.295M net loss in 2024 |
| Cash and cash equivalents | $62.802M | at September 30, 2025, up from $43.355M at December 31, 2024 |
| Change in fair value of contingent consideration | $19.999M | operating expense for the nine months ended September 30, 2025, contributing to increased total operating expenses |
| Common shares outstanding | 36,192,978 | as of November 5, 2025 |
| Net Loss | $10.4M | Increased from $8.8M year-over-year, indicating worsening profitability. |
| Revenue | $10.5M | Decreased by 6.3% from $11.2M, showing declining sales. |
| Accumulated Deficit | $234.3M | Grew from $223.9M, highlighting persistent unprofitability. |
| Cash and Cash Equivalents | $73.4M | Available liquidity for operations as of June 30, 2025. |
| Revenue Decline | 6.3% | Percentage decrease in revenue for the quarter ended June 30, 2025. |
| Total Assets | $35.4M | Represents the company's asset base as of March 31, 2025. |
Forward-Looking Statements
- {"claim":"ARCH Venture Fund VII will maintain a significant stake in 908 Devices Inc. for the foreseeable future.","entity":"ARCH Venture Fund VII, L.P.","targetDate":"December 31, 2024","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for 908 Devices Inc. (MASS)?
908 Devices Inc. has 41 recent SEC filings from Jan 2024 to May 2026, including 14 8-K, 7 10-Q, 7 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of MASS filings?
Across 41 filings, the sentiment breakdown is: 3 bullish, 1 bearish, 36 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find 908 Devices Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all 908 Devices Inc. (MASS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for 908 Devices Inc.?
Key financial highlights from 908 Devices Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for MASS?
The investment thesis for MASS includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at 908 Devices Inc.?
Key executives identified across 908 Devices Inc.'s filings include Burlington, MA, Fenel M. Eloi, Jeffery P. George, CLINTON BYBEE, KEITH CRANDELL and 1 others.
What are the main risk factors for 908 Devices Inc. stock?
Of MASS's 26 assessed filings, 1 were flagged high-risk, 10 medium-risk, and 15 low-risk.
What are recent predictions and forward guidance from 908 Devices Inc.?
Recent forward-looking statements from 908 Devices Inc. include guidance on {"claim":"ARCH Venture Fund VII will maintain a significant stake in 908 Devices Inc. for the foreseeable future.","enti.